Sicagen India Ltd: Share Price Analysis, Intrinsic Value & Fundamentals (2025)

Share Price and Basic Stock Data

Last Updated: March 8, 2025, 10:49 am

Market Cap	266 Cr.
Current Price	67.3
High / Low	119/42.6
Stock P/E	16.4
Book Value	123
Dividend Yield	0.89 %
ROCE	4.38 %
ROE	2.42 %
Face Value	10.0
PEG Ratio	0.38

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Sicagen India Ltd

Competitors of Sicagen India Ltd

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
Mitshi India Ltd	13.4 Cr.	15.2	36.9/14.1		3.06	0.00 %	5.68 %	4.57 %	10.0
Modella Woollens Ltd	5.63 Cr.	61.9	87.0/55.1		2.42	0.00 %	%	%	10.0
MRC Agrotech Ltd	28.4 Cr.	13.8	20.5/10.2		15.2	0.00 %	%	%	10.0
MRP Agro Ltd	149 Cr.	134	174/45.2	30.4	14.6	0.00 %	12.3 %	9.53 %	10.0
Muller and Phipps (India) Ltd	19.7 Cr.	315	726/190		23.8	0.00 %	%	%	10.0
Industry Average	3,774.62	N/A		70.05	N/A	N/A	11.64	8.09	N/A

All Competitor Stocks of Sicagen India Ltd

Quarterly Result

Metric	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Sales	229.73	315.55	163.87	245.82	258.19	227.42	166.43	180.08	227.70	221.23	232.26	197.71	210.26
Expenses	224.89	307.71	158.96	242.46	251.32	216.05	157.99	174.97	222.48	212.85	222.99	189.44	203.12
Operating Profit	4.84	7.84	4.91	3.36	6.87	11.37	8.44	5.11	5.22	8.38	9.27	8.27	7.14
OPM %	2.11%	2.48%	3.00%	1.37%	2.66%	5.00%	5.07%	2.84%	2.29%	3.79%	3.99%	4.18%	3.40%
Other Income	1.70	2.34	2.18	2.95	1.87	7.55	1.32	1.49	2.85	1.44	2.03	2.72	3.26
Interest	1.58	1.68	1.91	2.05	2.28	2.64	2.59	2.47	2.65	2.94	2.62	2.83	2.50
Depreciation	2.65	2.82	2.08	2.78	2.13	3.55	2.12	2.12	2.19	3.33	2.29	2.31	2.39
Profit before tax	2.31	5.68	3.10	1.48	4.33	12.73	5.05	2.01	3.23	3.55	6.39	5.85	5.51
Tax %	35.93%	27.46%	26.77%	37.16%	20.32%	12.25%	24.75%	35.32%	28.17%	12.96%	24.88%	29.23%	23.77%
Net Profit	1.48	4.12	2.27	0.93	3.45	11.17	3.80	1.30	2.32	3.09	4.80	4.14	4.20
EPS in Rs	0.37	1.04	0.57	0.24	0.87	2.82	0.96	0.33	0.59	0.78	1.21	1.05	1.06

Last Updated: February 28, 2025, 5:08 pm

Below is a detailed analysis of the quarterly data for Sicagen India Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:

For Sales, as of Dec 2024, the value is ₹210.26 Cr.. The value appears strong and on an upward trend. It has increased from 197.71 Cr. (Sep 2024) to ₹210.26 Cr., marking an increase of ₹12.55 Cr..
For Expenses, as of Dec 2024, the value is ₹203.12 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 189.44 Cr. (Sep 2024) to ₹203.12 Cr., marking an increase of ₹13.68 Cr..
For Operating Profit, as of Dec 2024, the value is ₹7.14 Cr.. The value appears to be declining and may need further review. It has decreased from 8.27 Cr. (Sep 2024) to ₹7.14 Cr., marking a decrease of 1.13 Cr..
For OPM %, as of Dec 2024, the value is 3.40%. The value appears to be declining and may need further review. It has decreased from 4.18% (Sep 2024) to 3.40%, marking a decrease of 0.78%.
For Other Income, as of Dec 2024, the value is ₹3.26 Cr.. The value appears strong and on an upward trend. It has increased from 2.72 Cr. (Sep 2024) to ₹3.26 Cr., marking an increase of ₹0.54 Cr..
For Interest, as of Dec 2024, the value is ₹2.50 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2.83 Cr. (Sep 2024) to ₹2.50 Cr., marking a decrease of 0.33 Cr..
For Depreciation, as of Dec 2024, the value is ₹2.39 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2.31 Cr. (Sep 2024) to ₹2.39 Cr., marking an increase of ₹0.08 Cr..
For Profit before tax, as of Dec 2024, the value is ₹5.51 Cr.. The value appears to be declining and may need further review. It has decreased from 5.85 Cr. (Sep 2024) to ₹5.51 Cr., marking a decrease of 0.34 Cr..
For Tax %, as of Dec 2024, the value is 23.77%. The value appears to be improving (decreasing) as expected. It has decreased from 29.23% (Sep 2024) to 23.77%, marking a decrease of 5.46%.
For Net Profit, as of Dec 2024, the value is ₹4.20 Cr.. The value appears strong and on an upward trend. It has increased from 4.14 Cr. (Sep 2024) to ₹4.20 Cr., marking an increase of ₹0.06 Cr..
For EPS in Rs, as of Dec 2024, the value is 1.06. The value appears strong and on an upward trend. It has increased from ₹1.05 (Sep 2024) to 1.06, marking an increase of ₹0.01.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: March 6, 2025, 2:51 pm

Metric	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM
Sales	1,027	620	645	601	711	738	820	699	542	836	895	795	861
Expenses	994	631	644	608	707	737	817	688	533	814	869	768	828
Operating Profit	34	-11	1	-7	3	1	3	11	9	22	27	28	33
OPM %	3%	-2%	0%	-1%	0%	0%	0%	2%	2%	3%	3%	3%	4%
Other Income	7	41	18	18	15	15	15	11	8	-0	15	7	9
Interest	11	7	6	6	7	9	9	9	5	6	9	11	11
Depreciation	4	6	5	5	4	5	6	10	10	11	11	10	10
Profit before tax	26	17	8	-1	8	2	3	3	1	5	22	14	21
Tax %	31%	1%	13%	-300%	3%	30%	95%	89%	322%	112%	18%	24%
Net Profit	18	17	7	1	7	1	0	0	-3	-1	18	10	16
EPS in Rs	4.52	4.27	1.67	0.27	1.89	0.29	0.03	0.09	-0.81	-0.15	4.50	2.65	4.10
Dividend Payout %	22%	19%	36%	224%	32%	206%	1,218%	550%	-74%	-162%	13%	23%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2013-2014	2014-2015	2015-2016	2016-2017	2017-2018	2018-2019	2021-2022	2022-2023	2023-2024
YoY Net Profit Growth (%)	-5.56%	-58.82%	-85.71%	600.00%	-85.71%	-100.00%	66.67%	1900.00%	-44.44%
Change in YoY Net Profit Growth (%)	0.00%	-53.27%	-26.89%	685.71%	-685.71%	-14.29%	166.67%	1833.33%	-1944.44%

Sicagen India Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 9 years from 2013-2014 to 2023-2024.

Growth

Compounded Sales Growth
10 Years:	3%
5 Years:	-1%
3 Years:	14%
TTM:	7%

Compounded Profit Growth
10 Years:	11%
5 Years:	193%
3 Years:	70%
TTM:	25%

Stock Price CAGR
10 Years:	18%
5 Years:	42%
3 Years:	41%
1 Year:	13%

Return on Equity
10 Years:	1%
5 Years:	1%
3 Years:	2%
Last Year:	2%

Last Updated: Unknown

Balance Sheet

Last Updated: February 12, 2025, 2:50 pm

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Sep 2024
Equity Capital	40	40	40	40	40	40	40	40	40	40	40	40	40
Reserves	421	441	439	443	345	353	343	336	355	383	400	420	447
Borrowings	103	73	48	60	89	97	119	96	79	95	121	121	150
Other Liabilities	112	119	84	76	105	114	184	133	72	140	68	118	62
Total Liabilities	675	673	610	619	578	604	685	605	546	656	629	699	698
Fixed Assets	60	64	59	57	183	203	151	168	168	141	141	140	141
CWIP	2	0	1	2	12	0	0	1	0	0	0	1	0
Investments	100	100	100	100	54	34	26	20	37	70	69	73	86
Other Assets	513	509	451	460	329	367	507	417	340	445	418	486	471
Total Assets	675	673	610	619	578	604	685	605	546	656	629	699	698

Below is a detailed analysis of the balance sheet data for Sicagen India Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:

For Equity Capital, as of Sep 2024, the value is ₹40.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded ₹40.00 Cr..
For Reserves, as of Sep 2024, the value is ₹447.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹420.00 Cr. (Mar 2024) to ₹447.00 Cr., marking an increase of 27.00 Cr..
For Borrowings, as of Sep 2024, the value is ₹150.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from ₹121.00 Cr. (Mar 2024) to ₹150.00 Cr., marking an increase of 29.00 Cr..
For Other Liabilities, as of Sep 2024, the value is ₹62.00 Cr.. The value appears to be improving (decreasing). It has decreased from ₹118.00 Cr. (Mar 2024) to ₹62.00 Cr., marking a decrease of 56.00 Cr..
For Total Liabilities, as of Sep 2024, the value is ₹698.00 Cr.. The value appears to be improving (decreasing). It has decreased from ₹699.00 Cr. (Mar 2024) to ₹698.00 Cr., marking a decrease of 1.00 Cr..
For Fixed Assets, as of Sep 2024, the value is ₹141.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹140.00 Cr. (Mar 2024) to ₹141.00 Cr., marking an increase of 1.00 Cr..
For CWIP, as of Sep 2024, the value is ₹0.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹1.00 Cr. (Mar 2024) to ₹0.00 Cr., marking a decrease of 1.00 Cr..
For Investments, as of Sep 2024, the value is ₹86.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹73.00 Cr. (Mar 2024) to ₹86.00 Cr., marking an increase of 13.00 Cr..
For Other Assets, as of Sep 2024, the value is ₹471.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹486.00 Cr. (Mar 2024) to ₹471.00 Cr., marking a decrease of 15.00 Cr..
For Total Assets, as of Sep 2024, the value is ₹698.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹699.00 Cr. (Mar 2024) to ₹698.00 Cr., marking a decrease of 1.00 Cr..

Notably, the Reserves (₹447.00 Cr.) exceed the Borrowings (150.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Cash from Operating Activity +	16	-14	2	-3	-41	-12	20	-37	31	-2	15	25
Cash from Investing Activity +	8	17	2	9	5	11	-5	45	-17	18	-4	-3
Cash from Financing Activity +	-17	-18	-11	4	22	-4	-12	-18	-12	-18	-13	-20
Net Cash Flow	7	-15	-6	10	-13	-5	3	-10	3	-2	-3	2

Free Cash Flow

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Free Cash Flow	-69.00	-84.00	-47.00	-67.00	-86.00	-96.00	-116.00	-85.00	-70.00	-73.00	-94.00	-93.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	44	75	61	71	75	91	119	108	115	107	76	114
Inventory Days	47	70	56	59	70	68	58	78	80	50	65	67
Days Payable	18	35	19	19	32	42	75	60	40	60	24	47
Cash Conversion Cycle	73	110	98	110	113	117	102	126	155	97	117	134
Working Capital Days	66	104	90	106	106	115	110	138	155	121	130	147
ROCE %	7%	2%	2%	1%	3%	2%	3%	3%	2%	4%	4%	4%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Promoters	38.78%	38.78%	45.66%	45.66%	50.57%	55.46%	55.46%	55.46%	55.46%	55.46%	60.39%	60.39%
FIIs	12.33%	12.33%	7.34%	7.34%	7.34%	7.34%	7.34%	7.34%	7.34%	7.34%	2.42%	2.42%
DIIs	0.61%	0.61%	0.60%	0.60%	0.60%	0.60%	0.60%	0.60%	0.60%	0.60%	0.60%	0.58%
Public	48.28%	48.28%	46.39%	46.38%	41.49%	36.60%	36.59%	36.60%	36.58%	36.59%	36.58%	36.61%
No. of Shareholders	29,644	28,982	27,494	25,689	25,314	25,199	25,160	25,114	24,726	24,309	24,855	24,453

Shareholding Pattern Chart

No. of Shareholders

This stock is not held by any mutual fund

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
FaceValue	10.00	10.00	10.00	10.00	10.00
Basic EPS (Rs.)	2.65	4.50	-0.15	-0.81	0.09
Diluted EPS (Rs.)	2.65	4.50	-0.15	-0.81	0.09
Cash EPS (Rs.)	5.12	7.17	2.61	1.70	2.65
Book Value[Excl.RevalReserv]/Share (Rs.)	116.19	111.08	106.73	99.75	94.82
Book Value[Incl.RevalReserv]/Share (Rs.)	116.19	111.08	106.73	99.75	94.82
Revenue From Operations / Share (Rs.)	201.02	226.26	211.31	136.88	176.61
PBDIT / Share (Rs.)	8.66	8.77	7.72	4.25	5.65
PBIT / Share (Rs.)	6.19	6.11	4.96	1.74	3.09
PBT / Share (Rs.)	3.50	5.47	1.27	0.36	0.86
Net Profit / Share (Rs.)	2.65	4.50	-0.15	-0.80	0.09
NP After MI And SOA / Share (Rs.)	2.65	4.50	-0.15	-0.80	0.09
PBDIT Margin (%)	4.30	3.87	3.65	3.10	3.19
PBIT Margin (%)	3.07	2.69	2.34	1.27	1.74
PBT Margin (%)	1.73	2.41	0.59	0.26	0.48
Net Profit Margin (%)	1.31	1.99	-0.07	-0.59	0.05
NP After MI And SOA Margin (%)	1.31	1.99	-0.07	-0.59	0.05
Return on Networth / Equity (%)	2.28	4.05	-0.14	-0.81	0.09
Return on Capital Employeed (%)	5.12	5.29	4.47	1.60	2.94
Return On Assets (%)	1.50	2.83	-0.09	-0.56	0.05
Long Term Debt / Equity (X)	0.00	0.00	0.00	0.01	0.05
Total Debt / Equity (X)	0.22	0.24	0.18	0.16	0.25
Asset Turnover Ratio (%)	1.20	1.39	0.85	0.66	0.76
Current Ratio (X)	2.17	2.38	2.01	2.57	2.08
Quick Ratio (X)	1.58	1.55	1.54	1.76	1.39
Inventory Turnover Ratio (X)	2.28	3.78	0.70	0.48	0.55
Dividend Payout Ratio (NP) (%)	22.59	5.55	-388.52	0.00	530.55
Dividend Payout Ratio (CP) (%)	11.69	3.49	22.96	0.00	18.19
Earning Retention Ratio (%)	77.41	94.45	488.52	0.00	-430.55
Cash Earning Retention Ratio (%)	88.31	96.51	77.04	0.00	81.81
Interest Coverage Ratio (X)	3.22	3.91	5.18	3.08	2.54
Interest Coverage Ratio (Post Tax) (X)	1.98	2.29	2.37	0.41	1.04
Enterprise Value (Cr.)	291.78	198.21	139.51	85.90	113.91
EV / Net Operating Revenue (X)	0.36	0.22	0.16	0.15	0.16
EV / EBITDA (X)	8.52	5.71	4.57	5.10	5.09
MarketCap / Net Operating Revenue (X)	0.29	0.13	0.10	0.10	0.04
Retention Ratios (%)	77.40	94.44	488.52	0.00	-430.55
Price / BV (X)	0.50	0.27	0.20	0.14	0.09
Price / Net Operating Revenue (X)	0.29	0.13	0.10	0.10	0.04
EarningsYield	0.04	0.14	-0.01	-0.05	0.01

After reviewing the key financial ratios for Sicagen India Ltd, here is a detailed analysis based on the latest available data and recent trends:

For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
For Basic EPS (Rs.), as of Mar 24, the value is 2.65. This value is below the healthy minimum of 5. It has decreased from 4.50 (Mar 23) to 2.65, marking a decrease of 1.85.
For Diluted EPS (Rs.), as of Mar 24, the value is 2.65. This value is below the healthy minimum of 5. It has decreased from 4.50 (Mar 23) to 2.65, marking a decrease of 1.85.
For Cash EPS (Rs.), as of Mar 24, the value is 5.12. This value is within the healthy range. It has decreased from 7.17 (Mar 23) to 5.12, marking a decrease of 2.05.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 116.19. It has increased from 111.08 (Mar 23) to 116.19, marking an increase of 5.11.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 116.19. It has increased from 111.08 (Mar 23) to 116.19, marking an increase of 5.11.
For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 201.02. It has decreased from 226.26 (Mar 23) to 201.02, marking a decrease of 25.24.
For PBDIT / Share (Rs.), as of Mar 24, the value is 8.66. This value is within the healthy range. It has decreased from 8.77 (Mar 23) to 8.66, marking a decrease of 0.11.
For PBIT / Share (Rs.), as of Mar 24, the value is 6.19. This value is within the healthy range. It has increased from 6.11 (Mar 23) to 6.19, marking an increase of 0.08.
For PBT / Share (Rs.), as of Mar 24, the value is 3.50. This value is within the healthy range. It has decreased from 5.47 (Mar 23) to 3.50, marking a decrease of 1.97.
For Net Profit / Share (Rs.), as of Mar 24, the value is 2.65. This value is within the healthy range. It has decreased from 4.50 (Mar 23) to 2.65, marking a decrease of 1.85.
For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 2.65. This value is within the healthy range. It has decreased from 4.50 (Mar 23) to 2.65, marking a decrease of 1.85.
For PBDIT Margin (%), as of Mar 24, the value is 4.30. This value is below the healthy minimum of 10. It has increased from 3.87 (Mar 23) to 4.30, marking an increase of 0.43.
For PBIT Margin (%), as of Mar 24, the value is 3.07. This value is below the healthy minimum of 10. It has increased from 2.69 (Mar 23) to 3.07, marking an increase of 0.38.
For PBT Margin (%), as of Mar 24, the value is 1.73. This value is below the healthy minimum of 10. It has decreased from 2.41 (Mar 23) to 1.73, marking a decrease of 0.68.
For Net Profit Margin (%), as of Mar 24, the value is 1.31. This value is below the healthy minimum of 5. It has decreased from 1.99 (Mar 23) to 1.31, marking a decrease of 0.68.
For NP After MI And SOA Margin (%), as of Mar 24, the value is 1.31. This value is below the healthy minimum of 8. It has decreased from 1.99 (Mar 23) to 1.31, marking a decrease of 0.68.
For Return on Networth / Equity (%), as of Mar 24, the value is 2.28. This value is below the healthy minimum of 15. It has decreased from 4.05 (Mar 23) to 2.28, marking a decrease of 1.77.
For Return on Capital Employeed (%), as of Mar 24, the value is 5.12. This value is below the healthy minimum of 10. It has decreased from 5.29 (Mar 23) to 5.12, marking a decrease of 0.17.
For Return On Assets (%), as of Mar 24, the value is 1.50. This value is below the healthy minimum of 5. It has decreased from 2.83 (Mar 23) to 1.50, marking a decrease of 1.33.
For Long Term Debt / Equity (X), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 23) which recorded 0.00.
For Total Debt / Equity (X), as of Mar 24, the value is 0.22. This value is within the healthy range. It has decreased from 0.24 (Mar 23) to 0.22, marking a decrease of 0.02.
For Asset Turnover Ratio (%), as of Mar 24, the value is 1.20. It has decreased from 1.39 (Mar 23) to 1.20, marking a decrease of 0.19.
For Current Ratio (X), as of Mar 24, the value is 2.17. This value is within the healthy range. It has decreased from 2.38 (Mar 23) to 2.17, marking a decrease of 0.21.
For Quick Ratio (X), as of Mar 24, the value is 1.58. This value is within the healthy range. It has increased from 1.55 (Mar 23) to 1.58, marking an increase of 0.03.
For Inventory Turnover Ratio (X), as of Mar 24, the value is 2.28. This value is below the healthy minimum of 4. It has decreased from 3.78 (Mar 23) to 2.28, marking a decrease of 1.50.
For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 22.59. This value is within the healthy range. It has increased from 5.55 (Mar 23) to 22.59, marking an increase of 17.04.
For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 11.69. This value is below the healthy minimum of 20. It has increased from 3.49 (Mar 23) to 11.69, marking an increase of 8.20.
For Earning Retention Ratio (%), as of Mar 24, the value is 77.41. This value exceeds the healthy maximum of 70. It has decreased from 94.45 (Mar 23) to 77.41, marking a decrease of 17.04.
For Cash Earning Retention Ratio (%), as of Mar 24, the value is 88.31. This value exceeds the healthy maximum of 70. It has decreased from 96.51 (Mar 23) to 88.31, marking a decrease of 8.20.
For Interest Coverage Ratio (X), as of Mar 24, the value is 3.22. This value is within the healthy range. It has decreased from 3.91 (Mar 23) to 3.22, marking a decrease of 0.69.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 1.98. This value is below the healthy minimum of 3. It has decreased from 2.29 (Mar 23) to 1.98, marking a decrease of 0.31.
For Enterprise Value (Cr.), as of Mar 24, the value is 291.78. It has increased from 198.21 (Mar 23) to 291.78, marking an increase of 93.57.
For EV / Net Operating Revenue (X), as of Mar 24, the value is 0.36. This value is below the healthy minimum of 1. It has increased from 0.22 (Mar 23) to 0.36, marking an increase of 0.14.
For EV / EBITDA (X), as of Mar 24, the value is 8.52. This value is within the healthy range. It has increased from 5.71 (Mar 23) to 8.52, marking an increase of 2.81.
For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 0.29. This value is below the healthy minimum of 1. It has increased from 0.13 (Mar 23) to 0.29, marking an increase of 0.16.
For Retention Ratios (%), as of Mar 24, the value is 77.40. This value exceeds the healthy maximum of 70. It has decreased from 94.44 (Mar 23) to 77.40, marking a decrease of 17.04.
For Price / BV (X), as of Mar 24, the value is 0.50. This value is below the healthy minimum of 1. It has increased from 0.27 (Mar 23) to 0.50, marking an increase of 0.23.
For Price / Net Operating Revenue (X), as of Mar 24, the value is 0.29. This value is below the healthy minimum of 1. It has increased from 0.13 (Mar 23) to 0.29, marking an increase of 0.16.
For EarningsYield, as of Mar 24, the value is 0.04. This value is below the healthy minimum of 5. It has decreased from 0.14 (Mar 23) to 0.04, marking a decrease of 0.10.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Sicagen India Ltd as of March 10, 2025 is: ₹39.40

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of March 10, 2025, Sicagen India Ltd is Overvalued by 41.46% compared to the current share price 67.30

Intrinsic Value of Sicagen India Ltd as of March 10, 2025 is: 56.21

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of March 10, 2025, Sicagen India Ltd is Overvalued by 16.48% compared to the current share price 67.30

Last 5 Year EPS CAGR: 42.67%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The company has higher reserves (394.31 cr) compared to borrowings (96.23 cr), indicating strong financial stability. The company has shown consistent growth in sales (674.15 cr) and profit (9.92 cr) over the years.	The stock has a low average ROCE of 3.08%, which may not be favorable. The stock has a high average Working Capital Days of 115.67, which may not be favorable. The stock has a high average Cash Conversion Cycle of 112.67, which may not be favorable.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Sicagen India Ltd:
1. Net Profit Margin: 1.31%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 5.12% (Industry Average ROCE: 11.64%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 2.28% (Industry Average ROE: 8.09%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 1.98
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 1.58
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 16.4 (Industry average Stock P/E: 70.05)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0.22
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

Sicagen India Ltd. is a Public Limited Listed company incorporated on 11/06/2004 and has its registered office in the State of Tamil Nadu, India. Company's Corporate Identification Number(CIN) is L74900TN2004PLC053467 and registration number is 053467. Currently company belongs to the Industry of Trading. Company's Total Operating Revenue is Rs. 476.96 Cr. and Equity Capital is Rs. 39.57 Cr. for the Year ended 31/03/2024.

INDUSTRY	ADDRESS	CONTACT
Trading & Distributors	4th Floor, SPIC House, No.88, Mount Road, Chennai (Madras) Tamil Nadu 600032	info@sicagen.com http://www.sicagen.com

Management
Name	Position Held
Mr. Ashwin C Muthiah	Chairman
Mr. Nandakumar Varma	Whole Time Director
Mr. R Chandrasekar	Director
Mr. Devaki Ashwin Muthiah	Director
Ms. Govindarajan Dattatreyan Sharma	Independent Director
Ms. Rita Chandrasekar	Independent Director
Mr. S Radhakrishnan	Independent Director
Mr. Batchu Sai Purshotham	Independent Director

FAQ

What is the latest intrinsic value of Sicagen India Ltd?

The latest intrinsic value of Sicagen India Ltd as on 10 March 2025 is ₹39.40, which is 41.46% lower than the current market price of 67.30, indicating the stock is overvalued by 41.46%. The intrinsic value of Sicagen India Ltd is calculated using PE ratio method. The stock has a market capitalization of ₹266 Cr. and recorded a high/low of ₹119/42.6 during the current fiscal year 2024-2025. As of Sep 2024, the company has reserves of ₹447 Cr and total liabilities of ₹698 Cr.

What is the Market Cap of Sicagen India Ltd?

The Market Cap of Sicagen India Ltd is 266 Cr..

What is the current Stock Price of Sicagen India Ltd as on 10 March 2025?

The current stock price of Sicagen India Ltd as on 10 March 2025 is ₹67.3.

What is the High / Low of Sicagen India Ltd stocks in FY 2024-2025?

In FY 2024-2025, the High / Low of Sicagen India Ltd stocks is ₹119/42.6.

What is the Stock P/E of Sicagen India Ltd?

The Stock P/E of Sicagen India Ltd is 16.4.

What is the Book Value of Sicagen India Ltd?

The Book Value of Sicagen India Ltd is 123.

What is the Dividend Yield of Sicagen India Ltd?

The Dividend Yield of Sicagen India Ltd is 0.89 %.

What is the ROCE of Sicagen India Ltd?

The ROCE of Sicagen India Ltd is 4.38 %.

What is the ROE of Sicagen India Ltd?

The ROE of Sicagen India Ltd is 2.42 %.

What is the Face Value of Sicagen India Ltd?

The Face Value of Sicagen India Ltd is 10.0.